The RAPID blood processing method can be used in humans and yields higher peptide levels as well as allows for assessment of the correct molecular form. Therefore, this method will be a valuable tool in peptide research.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
The RAPID blood processing method can be used in humans and yields higher peptide levels as well as allows for assessment of the correct molecular form. Therefore, this method will be a valuable tool in peptide research.
Research in the field of food intake regulation is gaining importance. This often includes the measurement of peptides regulating food intake. For the correct determination of a peptide's concentration, it should be stable during blood processing. However, this is not the case for several peptides which are quickly degraded by endogenous peptidases. Recently, we developed a blood processing method employing Reduced temperatures, Acidification, Protease inhibition, Isotopic exogenous controls and Dilution (RAPID) for the use in rats. Here, we have established this technique for the use in humans and investigated recovery, molecular form and circulating concentration of food intake regulatory hormones. The RAPID method significantly improved the recovery for 125I-labeled somatostatin-28 (+39%), glucagon-like peptide-1 (+35%), acyl ghrelin and glucagon (+32%), insulin and kisspeptin (+29%), nesfatin-1 (+28%), leptin (+21%) and peptide YY3-36 (+19%) compared to standard processing (EDTA blood on ice, p <0.001). High performance liquid chromatography showed the elution of endogenous acyl ghrelin at the expected position after RAPID processing, while after standard processing 62% of acyl ghrelin were degraded resulting in an earlier peak likely representing desacyl ghrelin. After RAPID processing the acyl/desacyl ghrelin ratio in blood of normal weight subjects was 1:3 compared to 1:23 following standard processing (p = 0.03). Also endogenous kisspeptin levels were higher after RAPID compared to standard processing (+99%, p = 0.02). The RAPID blood processing method can be used in humans, yields higher peptide levels and allows for assessment of the correct molecular form.
In light of the worldwide increasing prevalence of obesity1,2, research in the field of food intake regulation is gaining importance. While so far only one peptide is known that is peripherally produced and centrally acting to stimulate food intake, namely ghrelin3, within the past decades, a broad range of peptides has been identified that reduce food intake, e.g. leptin, peptide YY (PYY) and also glucagon-like peptide-1 (GLP-1) and insulin4, Therefore, in studies investigating the regulatory mechanisms of hunger and satiety peptide levels are often assessed and at the same time, it is assumed that the peptide studied is stab....
Access restricted. Please log in or start a trial to view this content.
The protocol was approved by the local ethics committee for human research (protocol number EA1/114/10).
1. Blood Processing
Access restricted. Please log in or start a trial to view this content.
RAPID blood processing increases the yield of 125I-radiolabeled peptides in human blood compared to standard blood processing.
After standard blood processing (EDTA blood on ice), the recovery of radiolabeled peptides was ~60% in 9/9 peptides (ranging from 48-68%, Figure 1A-K). RAPID processing improved the yield in all 125I-labeled peptides, namely in somatostatin-28 (+39%, Figure 1A), glucagon-like peptide-1 (+.......
Access restricted. Please log in or start a trial to view this content.
We reported before that the RAPID method for blood processing improved the recovery for 11/12 peptides compared to standard blood processing in rats6. In the present study we have shown that this method is also suited for the use in humans. Following RAPID processing, the recovery for 9 of 9 125I-labeled peptides tested was improved compared to standard blood processing (EDTA blood on ice). The observed improvement ranged from 19-39% which is likely to be relevant, especially under conditions when o.......
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
This work was supported by German Research Foundation STE 1765/3-1 (A.S.) and German Ministry for Education and Research 03IPT614A (C.G.). We thank Reinhard Lommel and Petra Buße for their excellent technical support as well as Karin Johansson and Christina Hentzschel for help with organization and execution of anthropometric measurements
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Diprotin A | Peptides International, Louisville, KY, USA | IDP-4132 | |
| E-64-d | Peptides International, Louisville, KY, USA | IED-4321-v | |
| Antipain | Peptides International, Louisville, KY, USA | IAP-4062 | |
| Leupeptin | Peptides International, Louisville, KY, USA | ILP-4041 | |
| Chymostatin | Peptides International, Louisville, KY, USA | ICY-4063 | |
| Sep-Pak C18 cartridges | Waters Corporation, Milford, MA, USA | WAT051910 | 360 mg, 55-105 µm |
| Acyl-ghrelin | Millipore, Billerica, MA, USA | 9088-HK | Radioactive |
| GLP-1 | Millipore, Billerica, MA, USA | 9035-HK | Radioactive |
| Glucagon | Millipore, Billerica, MA, USA | 9030 | Radioactive |
| Insulin | Millipore, Billerica, MA, USA | 9011S | Radioactive |
| Leptin | Millipore, Billerica, MA, USA | 9081-HK | Radioactive |
| Kisspeptin-10 | Phoenix Pharmaceuticals, Burlingame, CA, USA | T-048-56 | Radioactive |
| Nesfatin-1 | Phoenix Pharmaceuticals, Burlingame, CA, USA | T-003-26 | Radioactive |
| PYY3-36 | Phoenix Pharmaceuticals, Burlingame, CA, USA | T-059-02 | Radioactive |
| Somatostatin-28 | Phoenix Pharmaceuticals, Burlingame, CA, USA | T-060-16 | Radioactive |
| ZORBAX Rapid Resolution HT SB-C18 column | Agilent Technologies, Santa Clara, CA, USA | 822700-902 | 2.1 mm x 50 mm, 1.8 µm |
| Agilent 1200 LC | Agilent Technologies, Santa Clara, CA, USA | HPLC, several components, therefore no single catalog number | |
| Kisspeptin RIA | Phoenix Pharmaceuticals, Burlingame, CA, USA | # RK-048-56 | Radioactive |
| Total ghrelin RIA | Millipore, Billerica, MA, USA | # GHRT-89HK | Radioactive |
| Active ghrelin RIA | Millipore, Billerica, MA, USA | # GHRA-88HK | Radioactive |
| SigmaStat 3.1 | Systat Software, San Jose, CA, USA | online download |
Access restricted. Please log in or start a trial to view this content.